DXCM - DexCom - Stock Forecast

Healthcare - Sector

Coverage Profile Stock analysts Price Targets & Ratings Chart Insider Trading

DXCM is currently covered by 18 analysts with an average price target of $92. This is a potential upside of $17.54 (23.56%) from yesterday's end of day stock price of $74.46.

DexCom's activity chart (see below) currently has 416 price targets and 281 ratings on display. The stock rating distribution of DXCM is 80.95% BUY and 19.05% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 82.95% with an average time for these price targets to be met of 205.14 days.

Highest price target for DXCM is $120, Lowest price target is $82, average price target is $92.

Most recent stock forecast was given by STEVEN LICHTMAN from OPPENHEIMER on 25-Oct-2024. First documented stock forecast 18-Oct-2012.

What is DexCom?

Dexcom is a medical device company that specializes in continuous glucose monitoring (CGM) systems for diabetes management.

Founded in 1999, Dexcom continuously improves its CGM tech, releasing popular diabetes management products.

Dexcom’s mission is to help people with diabetes manage their condition more effectively and improve their overall health outcomes. Dexcom’s CGM systems provide real-time glucose data, helping users manage blood glucose levels and improve their health.

What Made DexCom Famous?

DexCom’s CGM systems have revolutionized diabetes management. Traditional glucose monitoring methods, such as finger stick testing, are invasive and require frequent testing, which can be inconvenient and painful. DexCom’s CGM offers non-invasive, real-time glucose monitoring without frequent finger stick testing, improving diabetes management. Dexcom’s G6 and G7 systems offer finger-stick-free continuous glucose monitoring, the company’s flagship products.

What Are the Famous Products or Services of DexCom?

Dexcom G6 and Dexcom G7

The company develops these integrated CGM systems for diabetes management. These devices continuously monitor glucose levels and offer real-time glucose data, and are small and wearable. The G6 and G7 systems are designed to be more accurate and easier to use than previous generations of Dexcom’s CGM systems. They also offer extended wear times, no finger stick calibration, and compatibility with a wider range of smart devices.

Dexcom Share

A remote monitoring system that allows users to share their glucose data with others, such as family members or healthcare providers. The CGM system transmits glucose data to a mobile app, which authorized users can access on their mobile devices. This feature is particularly useful for parents of children with diabetes or for caregivers who need to monitor the glucose levels of their patients.

Dexcom Real-Time API

A software tool that enables third-party developers to integrate real-time CGM data into their digital health apps and devices. The API allows developers to access Dexcom’s glucose data and incorporate it into their apps for specific and permitted use cases. This includes non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions.

Dexcom ONE

Designed to replace finger stick blood glucose testing for diabetes treatment decisions. It includes a small, wearable device that continuously monitors glucose levels in the body that provides real-time glucose data to the user. The Dexcom ONE system is designed to be more accurate and less invasive than traditional fingerstick testing. It also offers extended wear times and no finger stick calibration.